[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.166.22. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 723
Citations 0
Comment & Response
January 20, 2015

Long-Acting β-Agonists With vs Without Inhaled Corticosteroids for COPD—Reply

Author Affiliations
  • 1Department of Medicine, University of Toronto, Toronto, Ontario, Canada
  • 2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
  • 3Division of Respirology, University of Toronto, Toronto, Ontario, Canada
JAMA. 2015;313(3):305-306. doi:10.1001/jama.2014.16479

In Reply Drs Suissa and Ernst correctly note that we inadvertently erred in describing the follow-up period used in their study.1 Also, we agree that our wording could have been interpreted as implying that their study primarily or exclusively evaluated patients who died of pneumonia and that they did not adjust for LABA use, which is incorrect and was not our intended meaning. These points have been clarified in the online version of the article’s supplement.

First Page Preview View Large
First page PDF preview
First page PDF preview
×